Bioage Labs, Inc.(BIOA)
Search documents
Contact Levi & Korsinsky by March 10, 2025 Deadline to Join Class Action Against BioAge Labs, Inc.(BIOA)
ACCESSWIRE Newsroom· 2025-01-17 21:30
Contact Levi & Korsinsky by March 10, 2025 Deadline to Join Class Action Against BioAge Labs, Inc.(BIOA) ...
BIOA LEGAL ALERT: BioAge Labs Sued after Stock Drops 76% - Investors with Losses are Urged to Contact BFA Law before March 10 Class Action Deadline
ACCESSWIRE Newsroom· 2025-01-17 20:18
BIOA LEGAL ALERT: BioAge Labs Sued after Stock Drops 76% - Investors with Losses are Urged to Contact BFA Law before March 10 Class Action Deadline ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
ACCESSWIRE Newsroom· 2025-01-17 18:15
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA ...
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA
ACCESSWIRE Newsroom· 2025-01-17 18:00
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA ...
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA
ACCESSWIRE Newsroom· 2025-01-17 17:30
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA ...
Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
ACCESSWIRE Newsroom· 2025-01-17 16:15
Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA ...
Levi & Korsinsky Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline
ACCESSWIRE Newsroom· 2025-01-17 14:30
Core Viewpoint - BioAge Labs, Inc. (BIOA) is facing a class action lawsuit, which has been notified to its shareholders, indicating potential legal challenges for the company [1] Group 1 - The lawsuit is related to allegations that BioAge Labs may have misled investors regarding its business practices and financial performance [1] - Shareholders are urged to be aware of an upcoming deadline related to the class action lawsuit, which may impact their rights and claims [1] - The notification serves as a reminder for investors to stay informed about the legal proceedings and their implications for the company's future [1]
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against BioAge Labs, Inc.
ACCESSWIRE Newsroom· 2025-01-17 14:15
Core Viewpoint - The Schall Law Firm is inviting shareholders who have incurred losses to participate in a securities fraud case against BioAge Labs, Inc. [1] Group 1 - The law firm is focusing on shareholders who have experienced financial losses related to BioAge Labs, Inc. [1] - The case is centered around allegations of securities fraud, indicating potential misconduct by the company [1] - Shareholders are encouraged to join the legal action to seek recovery for their losses [1]
BIOA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
ACCESSWIRE Newsroom· 2025-01-17 12:00
BIOA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! ...
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
Prnewswire· 2025-01-17 10:45
NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to BioAge's registration statement for the initial public offering held on or about September 26 ...